NXTC
insider transactionsNextCure, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 365d
-
Grant·A
Director
$0
2.3K sh
Own New
-
Grant·A
Director
$0
3.5K sh
Own New
-
Grant·A
Director
$0
2.3K sh
Own New
-
Grant·A
Director
$0
2.3K sh
Own New
-
Grant·A
Director
$0
2.3K sh
Own New
-
Grant·A
Director
$0
2.3K sh
Own New
-
Grant·A
Sr VP, General Counsel
$0
8.3K sh
Own New
-
Grant·A
Sr VP, Dev. & Mfg.
$0
8.3K sh
Own New
-
Grant·A
Chief Operating Officer
$0
14.7K sh
Own New
-
Grant·A
Richman Michael KEY
President & CEO
$0
38.2K sh
Own New
-
Grant·A
Chief Medical Officer
$0
14.7K sh
Own New
-
Grant·A
Chief Financial Officer
$0
14.7K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Webster Stephen W | Grant A | 2.3K | $0 |
| Jun 18, 2026 | KABAKOFF DAVID S | Grant A | 3.5K | $0 |
| Jun 18, 2026 | Jones Elaine V | Grant A | 2.3K | $0 |
| Jun 18, 2026 | Houston John G | Grant A | 2.3K | $0 |
| Jun 18, 2026 | Feigal Ellen | Grant A | 2.3K | $0 |
| Jun 18, 2026 | Borgman Anne Elizabeth | Grant A | 2.3K | $0 |
| Jan 30, 2026 | Shaw Kevin G. | Grant A | 8.3K | $0 |
| Jan 30, 2026 | Kundu Sourav | Grant A | 8.3K | $0 |
| Jan 30, 2026 | Mayer Timothy | Grant A | 14.7K | $0 |
| Jan 30, 2026 | Richman Michael KEY | Grant A | 38.2K | $0 |
| Jan 30, 2026 | Guha Udayan | Grant A | 14.7K | $0 |
| Jan 30, 2026 | Cobourn Steven P. KEY | Grant A | 14.7K | $0 |
Buy Sell Non-market (grant · exercise · gift)
About NXTC insider trading
This page tracks insider transactions for NextCure, Inc. (NXTC) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.